跳至主要内容
临床试验/NCT05223400
NCT05223400已完成不适用

Drug Use Evaluation Study of Clindamycin in Critical Care Units in Alexandria Main University Hospital

Alexandria University1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2022年3月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
99
试验地点
1
主要终点
the number of prescriptions with appropriate indications of clindamycin will be counted during the retrospective observation of all prescriptions

研究概览

简要总结

Irrational use of antibiotics is a one of the main health system problems,it leads to antibiotic resistance,increasing antibiotics side effects and the total cost. This study is a medication use evaluation study aims to evaluate intravenous clindamycin prescribing practice in critical care units in Alexandria Main University Hospital.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years old or more .
  • Patients on clindamycin as an empirical treatment.
  • Patients started clindamycin as an emperical treatment in other departments but the physician approved to continue it in critical care.

排除标准

  • Children (less than 18 years old)
  • Patients started clindamycin as a defenitive treatment (based on microbiological culture results).

结局指标

主要结局

the number of prescriptions with appropriate indications of clindamycin will be counted during the retrospective observation of all prescriptions

时间窗: 1 month

appropriateness of clindamycin indication will be determined according to IDSA guidelines.

次要结局

  • the number of prescriptions with duplication of therapy with clindamycin will be counted during the retrospective observation of all prescriptions(1 month)
  • the number of patients who had diarrhea as a main side effect of clindamycin(1 month)
  • the number of patients who had severe drug interactions with clindamycin(1 month)
  • to calculate the total cost of clindamycin.(1 month)
  • Total clindamycin DDD defined daily doses and clindamycin defined daily doses per 1000 patients days.(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heba Shaker

supervisor of clinical pharmacy unit in Alexandria Main University Hospital

Alexandria University

研究点 (1)

Loading locations...

相似试验

Drug Use Evaluation of Clindamycin in Critical Care... | 临床试验